Ares Capital Corporation ARCC announced that it has priced its
public offering of 14,300,000 shares of its common stock. Ares Capital has
granted the underwriters an option to purchase up to an additional 2,145,000
shares of common stock. The offering is subject to customary closing
conditions and is expected to close on December 13, 2013. The offering of the
shares is being made under Ares Capital's shelf registration statement (as
amended), which was filed with, and declared effective by, the Securities and
Exchange Commission. On December 9, 2013, the official close price of Ares
Capital's common stock on The NASDAQ Global Select Market under the symbol
“ARCC” was $18.29 per share.
Ares Capital expects to use the net proceeds of this offering to repay certain
outstanding indebtedness under its debt facilities and, to the extent not used
for such purpose, for general corporate purposes, which may include investing
in portfolio companies in accordance with its investment objective.
Investors are advised to carefully consider the investment objective, risks,
charges and expenses of Ares Capital before investing. The preliminary
prospectus supplement dated December 9, 2013 and the accompanying prospectus
dated June 17, 2013, which have been filed with the Securities and Exchange
Commission, contain this and other information about Ares Capital and should
be read carefully before investing.
Morgan Stanley, BofA Merrill Lynch and Wells Fargo Securities are acting as
joint book-running managers for this offering. Deutsche Bank Securities and
Goldman, Sachs & Co. are acting as joint lead managers and Barclays, Credit
Suisse Securities (USA) LLC, and Keefe, Bruyette & Woods, a Stifel Company,
are acting as co-managers for this offering. The underwriters may offer the
shares of common stock from time to time for sale in one or more transactions
on The NASDAQ Global Select Market, in the over-the-counter market, through
negotiated transactions or otherwise at market prices prevailing at the time
of sale, at prices related to prevailing market prices or at negotiated
prices.
The information in the preliminary prospectus supplement, the accompanying
prospectus and this press release is not complete and may be changed. The
preliminary prospectus supplement, the accompanying prospectus and this press
release are not offers to sell any securities of Ares Capital and are not
soliciting an offer to buy such securities in any state where such offer and
sale is not permitted.
The offering may be made only by means of a preliminary prospectus supplement
and an accompanying prospectus, copies of which may be obtained from Morgan
Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, NY, 10014, Attn:
Prospectus Department, tel: (866) 718-1649 or e-mail
prospectus@morganstanley.com; BofA Merrill Lynch, 222 Broadway, New York, NY
10038, Attn: Prospectus Department, or e-mail dg.prospectus_requests@baml.com;
or Wells Fargo Securities, LLC, 375 Park Avenue, New York, NY 10152, Attn:
Equity Syndicate Dept., tel.: (800) 326-5897 or e-mail
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in